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Hispanics are at increased risk of morbidity and mortality due to their high prevalence of diabetes and poor 
glycemic control. Strength training is the most effective lifestyle intervention to increase muscle mass but limited 
data is available in older adults with diabetes. We determined the influence of strength training on muscle quality 
(strength per unit of muscle mass), skeletal muscle fiber hypertrophy, and metabolic control including insulin 
resistance (Homeostasis Model Assessment –HOMA-IR), C-Reactive Protein (CRP), adiponectin and Free Fatty 
Acid (FFA) levels in Hispanic older adults. Sixty-two community-dwelling Hispanics (>55 y) with type 2 diabetes 
were randomized to 16 weeks of strength training plus standard care (ST group) or standard care alone (CON 
group). Skeletal muscle biopsies and biochemical measures were taken at baseline and 16 weeks. The ST group 
show improved muscle quality (mean±SE: 28±3) vs CON (-4±2, p<0.001) and increased type I (860±252µm2) and 
type II fiber cross-sectional area (720±285µm2) compared to CON (type I: -164±290µm2, p=0.04; and type II: 
-130±336µm2, p=0.04). This was accompanied by reduced insulin resistance [ST: median (interquartile range) 
-0.7(3.6) vs CON: 0.8(3.8), p=0.05]; FFA (ST: -84±30µmol/L vs CON: 149±48µmol/L, p=0.02); and CRP [ST: 
-1.3(2.9)mg/L vs CON: 0.4(2.3)mg/L, p=0.05]. Serum adiponectin increased with ST [1.0(1.8)µg/mL] compared 
to CON [-1.2(2.2)µg/mL, p<0.001]. Strength training improved muscle quality and whole-body insulin sensitivity. 
Decreased inflammation and increased adiponectin levels were related with improved metabolic control. Further 
studies are needed to understand the mechanisms associated with these findings. However, these data show that 
strength training is an exercise modality to consider as an adjunct of standard of care in high risk populations 
with type 2 diabetes. 
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1.  Introduction 
Type 2 diabetes is a chronic disease characterized 
by hyperglycemia and disturbances of carbohydrate, 
fat and protein metabolism [1]. Diet, exercise and 
weight loss are cornerstones of diabetes management 
to improve glycemic control, reduce muscle wasting 
and mortality [2]. Targeted interventions are needed to 
improve long-term diabetes control in high risk groups, 
like Hispanic older adults for whom diabetes and poor 
glycemic control are prevalent [3]. 
Endurance training has traditionally been 
advocated for people with diabetes [4]. More recently, 
strength training has been tested as a means to build 
muscle mass, strength and quality in healthy 
individuals and those suffering from chronic 
conditions like diabetes. Muscle quality, defined as 
maximal force production per unit of muscle mass, 
may be a better indicator of muscle  function than 
strength alone [5]. There are many properties of 
skeletal muscle which contribute to muscle quality 
including fiber type, composition and size; contractile 
properties; innervation; capillarity and metabolic 
capacity [6]. Muscle quality has been shown to be 
lower in older than younger individuals [7] and 
recently, it has been noted that people with diabetes 
have significantly lower muscle quality than those 
without the disease [8]. 
Adipokines are soluble proteins released from 
adipocytes in response to metabolic signals and are 
involved in insulin resistance and inflammation [9]. In 
contrast to other adipokines, adiponectin levels 
decrease with increasing fat mass and higher levels of 
plasma adiponectin are independently associated with 
reduced risk of type 2 diabetes in healthy individuals 
[10]. Adiponectin also has an anti-inflammatory action 
[11]. Since diabetes and obesity are considered chronic 
inflammatory states, we chose to measure a prominent 
systemic marker of low-grade tissue inflammation, 
C-reactive Protein (CRP) [12]. Circulating levels of 
CRP are associated with adiponectin [12] and 
individuals with the metabolic syndrome have higher Int. J. Med. Sci. 2007, 4 
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levels of CRP [13].  
There is relatively sparse amount of literature on 
high-intensity strength training and diabetes in high 
risk populations. Maiorana et al. [14] circuit training 
intervention found increase in muscle mass and 
strength, and cardiovascular fitness. Similalry, Cauza 
et al. [15] , Tokmakidis et al. [16], and Eriksson et al [17] 
showed that moderate-intensity strength training is an 
effective exercise modality to achieve glycemic control 
and improve insulin sensitivity in subjects with type 2 
diabetes. More recently, two randomized control trials 
of high-intensity strength training by Dunstan et al. [18] 
and Castaneda et al. [19], with the latter representing 
the parent study from which the present investigation 
has been derived; have shown that long-term strength 
significantly improves glycemic control and increases 
skeletal muscle mass. In addition, strength training has 
also been shown to influence a number of factors 
associated with whole-body insulin sensitivity such as 
CRP and pro-inflammatory cytokines [20]. A few 
recent studies have investigated exercise training on 
circulating adiponectin levels. These studies have 
shown that greater increases in adiponectin levels are 
associated with higher intensities of endurance 
exercise training [21, 22] and strength training [23]. 
To our knowledge no previous studies have 
investigated the effects of high-intensity strength 
training on muscle quality and whole-body insulin 
sensitivity in a high risk population of older adults 
with diabetes. This is why we chose to conduct this 
investigation in Hispanic older adults with type 2 
diabetes. We hypothesized that 16 weeks of 
high-intensity strength training would result in 
improved muscle quality, skeletal muscle fiber 
hypertrophy as well as improved metabolic control (as 
measured by reduced insulin resistance and 
inflammation) in these study subjects.  
2.  Research Design and Methods 
Subject characteristics 
Sixty-two Hispanic individuals, 55 years and 
older with type 2 diabetes were randomized to 16 
weeks of strength training plus standard care (ST 
group, n=31) or standard care alone (CON group, 
n=31). General methodology has been previously 
reported [19]. Briefly, diabetes was confirmed by a 
fasting plasma glucose ≥ 7.0 mmol/L or use of diabetic 
medications. Exclusion criteria included the following: 
myocardial infarction (within past 6 months), any 
unstable chronic condition including dementia, 
alcoholism, dialysis, retinal hemorrhage or detachment, 
or current participation in resistance training. Written 
informed consent was given in Spanish, as approved 
by the Institutional Review Board at Tufts 
University-New England Medical Center.  
Intervention 
Strength training (ST) group 
Subjects reported to the Jean Mayer USDA 
Human Nutrition Research Center on Aging (HNRCA) 
3x/week for 16 weeks for exercise training. Exercise 
sessions included 35-min strength training using five 
pneumatic machines: upper back, chest press, leg press, 
knee extension and flexion (Keiser Sports Health 
Equipment Inc., Fresno, CA) with 3 sets of 8 repetitions 
on each machine preceded by 5-min warm-up and 
ended with 5-min cool-down. Training intensity 
during wks 1-8 were 60-80% of baseline 1-repetition 
maximum (1RM), and during wks 10-14 were 70-80% 
of mid-study 1RM. Postprandial blood glucose was 
monitored before and after exercise using a One Touch 
Glucometer (Lifescan Inc., Johnson & Johnson Co., 
Milpitas, CA). 
Control (CON) group 
Subjects randomized to this group were asked to 
continue their usual standard of care. This included 
actions known to favorably affect health  outcomes 
such as: glycemic control, blood glucose 
self-monitoring, engaging in healthy food choices and 
physical activity, and compliance with medications 
and doctor’s visits [24]. Subjects in this group received 
phone calls every other week and came to the HNRCA 
for testing at baseline and 16 weeks. We chose this 
approach rather than an attention-control to test the 
effect of standard of care alone. 
Outcome measures  
Baseline measures were taken prior to 
randomization. Post-intervention measures were 
performed in a blinded manner except for muscle 
strength. 
Body composition 
Body mass index (BMI) was calculated from body 
weight and height as kg/m2. Whole-body and regional 
lean and fat mass were determined by Dual-X ray 
absorptiometry (DXA) using an Hologic QDR2000 
(Waltham, MA) scanner operating in array mode with 
software 5.64A, with a coefficient of variation of 1.4% 
and 1.8% for lean and fat mass, respectively [25]. DXA 
has been validated against multicompartment 
methods and in-vivo neutron inelastic scattering [25]. 
Waist circumference was determined by standard 
technique. 
Muscle strength 
Muscle strength 1RM was assessed twice at 
baseline and once during week 16 on each training 
machine. Initial training loads and analyses used the 
highest of the two 1RM values assessed at baseline. 
The coefficient of variation for repeated measures at 
baseline was less than 10%. Upper and lower body 
strength at baseline and 16 weeks was calculated as the 
sum of 1RM measures for each upper and lower body 
exercise performed. 
Muscle quality 
Skeletal muscle quality as defined by the ratio of 
strength per unit of muscle mass [7]. There are a 
number of ways to express muscle quality. We chose to 
calculate muscle quality from leg 1RM strength (leg 
press, knee extension and knee flexion) in kg divided 
by leg lean body mass in kg, without bone mineral Int. J. Med. Sci. 2007, 4 
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content, as measured by DXA. The appendicular 
fat-free mass derived from leg measurement of DXA is 
assumed to be a valid estimation of skeletal muscle 
[26].  
Skeletal muscle histology: Fiber type and cross-sectional area 
(CSA) 
Skeletal muscle samples were obtained from a 
sub-set of individuals who agreed to have the 
procedure (n = 24 ST, n = 18 CON). Percutaneous 
needle biopsies were taken from the non-dominant 
vastus lateralis using a 5 mm Bergstrom needle [27] at 
baseline and 72 h after final 1RM strength testing (wk 
16). Muscle samples were oriented longitudinally, 
mounted in embedding medium (Tissue-Tek OCT, 
Miles Laboratories, Elkhart, IN), and frozen in 
isopentane cooled in liquid nitrogen. Transverse 
sections (10µm) were cut using a Leica 
CM1850-Cryostat (Leica Microsystem, Nussloch, 
Germany). Staining for myofibrillar adenosine 
triphosphatase (mATPase) was done at pH 4.3 [28]. 
Type I and II muscle fiber cross-sectional areas were 
determined in 75-250 fibers for each subject at each 
time point. Samples were analyzed under light 
microscopy and areas determined using an Image 
Software version 1.39 (Dr. W. Rasband, National 
Institute of Aging, Bethesda, MD), modified for our 
laboratory by Chun-ShanYam Ph.D. (SyLoc 
Consulting LLP, Lexington, MA) with CV of 3% [28].  
Biochemical measures 
Fasting blood measures were taken at baseline 
and 72 h after final 1RM strength testing (wk 16). 
Fasting plasma glucose was determined by the 
hexokinase enzymatic method (Sigma Diagnostics, St. 
Louis, MO) and insulin levels by radioimmunoassay 
(ICN Biomedical Inc., Costa Mesa, CA) with CV of 5%. 
Free fatty acids (FFA) were determined by in vitro 
enzymatic colorimetric endpoint method for 
quantification of non-esterified FFA in serum (Walo 
Chemicals USA, Inc., Richmond, VA) with CV of 6%. 
Serum C-Reactive Protein (CRP) levels were measured 
by an immunoturbidimetric commercially available kit 
in a Cobas Fara II automated centrifugal analyzer (CRP 
SPQ Test System, DiaSorin Inc., Stillwater, MN) with 
CV of 5%. Serum adiponectin was determined in 
duplicate using a highly sensitive, quantitative 
sandwich enzyme immunoassay technique (Human 
Adiponectin/Acrp30 Quantikine Immunoassay, R&D 
Systems, Minneapolis, MN) with CV of 3%. 
HOMA-IR 
Whole-body insulin resistance was estimated 
using the homeostasis model assessment of insulin 
resistance (HOMA-IR) which correlates well with the 
euglycemic hyperinsulinemic clamp in people with 
diabetes [29]. The following formula was used: 
HOMA-IR = [fasting Glucose (mmol/L)*fasting 
Insulin (uU/ml)]/22.5. 
Subject Monitoring 
Subjects continued their usual medical care and 
received Spanish translated recommendations for 
diabetes self-management [24]. They were not given 
dietary counseling other than to follow standard 
recommendations given by their health care providers. 
Both groups were administered a weekly symptom 
checklist to document blood glucose self-monitoring, 
diabetes control, medical visits, medication changes, 
acute illness, and hospitalizations. Past seven-day, 
self-reported leisure and household physical activity 
was monitored using the Physical Activity Scale for the 
Elderly [30]. Dietary intake was assessed using a food 
frequency questionnaire adapted for the Hispanic 
population [31].  
Table 1: Baseline Subject Characteristics 
 ST  Group   
N=31 
CON Group   
N=31 
P valuea 
Age (years)  66 ± 2  66 ± 1  0.76 
Sex (male/female)  21/10  19/12  0.59 
BMI (kg/m2)  30.9 ± 1.1  31.2 ± 1.0  0.81 
Whole-Body Fat Mass (kg)  35.0 ± 2.2  33.7 ± 2.4  0.70 
Waist Circumference (cm)  99.7 ± 2.3  100.1 ± 2.6  0.63 
Fasting Glucose (mmol/L)  8.79 ± 0.48  9.85 ± 0.69  0.21 
Fasting Insulin (pmol/L)  116 (124)  115 (131)  0.58 
HOMA-IR  7.1 (5.7)  6.7 (9.0)  0.96 
Glycosylated Hb A1C (%)  8.7 ± 0.3  8.4 ± 0.3  0.58 
Diabetes Duration (y)  8 ± 1  11 ± 1  0.22 
Insulin Therapy (n)  15  5  0.02 
Data are mean ± SE except for not normally distributed variables (insulin 
and HOMA-IR) which show median (interquartile range).  
a Baseline comparisons between groups were assessed by 
independent sample t-test comparisons for continuous and log 
transformed variables or Chi-square for categorical variables. 
Statistical Analysis 
Statistical analysis was based on intention-to-treat 
analysis using SPSS 12.0 for Windows (SPSS, Inc., 
Evanston, IL). Results were considered statistically 
significant with a two-tailed p-value < 0.05. Data are 
shown as mean and standard error (SE), except for 
non-normally distributed variables (insulin, HOMA-IR, 
CRP, adiponectin) for which group median and 
interquartile ranges are shown. The non-normally 
distributed variables were log-transformed, checked 
for normality after log transformation, and used as 
continuous log-transformed variables for analyses. 
Baseline comparisons were assessed by independent 
sample t-test or Chi-square as appropriate. Repeated 
measures analysis of covariance (ANCOVA) was used 
to assess differences in outcome measures (muscle 
quality, muscle fiber size and metabolic parameters) 
between the two groups across time, as well as 
time-by-group interactions adjusting for insulin 
therapy as this was the only variable different between 
groups at baseline (Table 1), and for the observed 
changes in leisure time physical activity and diabetes 
medications observed after the intervention. 
Secondary model-building stepwise regression 
analyses of the change (weeks 16-0) in type I muscle 
fiber CSA (as the dependent variable) were carried out 
by group in order to determine the associations of 
selected factors on the change in type I CSA. 
Independent variables included in the models were the 
changes in HOMA-IR, CRP, adiponectin, and FFA.  Int. J. Med. Sci. 2007, 4 
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3.  Results  
Baseline characteristics and study monitoring 
The subject characteristics at baseline are shown 
in Table 1. The ST and CON groups did not differ by 
age, sex, body composition or metabolic characteristics, 
except that a higher proportion of prescribed insulin 
therapy was found in participants randomized to the 
ST group. As previously described [19], diabetic 
medication regimens were reduced in 22 out of the 31 
(72 %) subjects in the ST group with 13 subjects having 
a reduction in sulfonylureas, 7 in biguanides, and 2 in 
insulin therapy. In contrast, CON subjects showed the 
opposite pattern. Thirteen out of 31 (42 %) subjects 
experienced an increase in their diabetes medication 
dosages, with 4 subjects having an increase in 
sulfonylureas, 6 in biguanides, and 3 in insulin therapy. 
The changes in medications, as prescribed by subjects’ 
primary care physicians, were different between 
groups (p= 0.03). Another change resulting from the 
intervention was a significant increase in leisure time 
physical activity in the ST group, outside of training 
regimen, as compared to CON subjects (ST: 187 ± 27 
kcal/wk vs CON: -50 ± 19 kcal/week; p<0.001). Finally, 
there was no change in dietary intake as a result of this 
intervention (data not shown). 
Muscle quality and muscle fiber size 
Compliance to strength training was 90 ± 10 %. 
Muscle strength, lean tissue mass, muscle quality, and 
vastus lateralis muscle fiber cross-sectional area are 
shown in Table 2. Mean upper and lower body muscle 
strength was significantly improved in with ST 
compared to CON subjects. This is not surprising 
given that the mean training intensity achieved by the 
ST group was 70.2 ± 1.3 % of 1RM (range: 66 to 75 %). 
Whole-body lean body mass also increased in the ST 
group, while leg lean tissue mass did not change 
between the groups. Muscle quality, a functional 
measurement of strength per unit volume of muscle 
(calculated from lower body muscle strength values in 
kg and leg lean tissue mass in kg), was significantly 
improved in the ST group vs CON group. Finally, we 
observed hypertrophy of type I and type II muscle 
fiber CSA in the ST group compared to CON subjects.  
Metabolic control 
As shown in Table 3, overall glycemic control (as 
determined by glycosylated hemoglobin A1C levels) 
was improved with strength training, while there was 
virtually no change in the CON group. Similarly, 
insulin resistance determined by HOMA-IR, was 
significantly reduced in the ST group after 16 weeks of 
training compared with the CON group. The change in 
HOMA-IR was driven by a reduction in insulin 
concentration in the ST group, albeit not statistically 
significant when compared to the CON group. In 
addition, serum FFA and CRP levels decreased in the 
ST group compared to CON subjects. Finally, 
circulating adiponectin concentrations increased 
significantly in the ST group compared with controls.  
Table 2: Muscle Quality and Muscle Fiber Size 
ST Group    CON Group   
N=31 Change N=31 Change 
P valuea 
Upper Body Muscle Strength (kg)     
Baseline 66 ± 4   62  ± 4     
Final 90  ± 6  24 ± 2  58 ± 4  - 4 ± 2  <0.001 
Lower Body Muscle Strength (kg) 
Baseline 338  ± 
27 
 300  ± 
28  
  
Final 568  ± 
34 
173 ± 19  285 ± 
27 
 -  19  ± 7  <0.001 
Whole-Body Lean Tissue Mass (kg) 
Baseline 44.3  ± 
1.7 
 44.9  ± 
1.9 
  
Final 45.5  ± 
1.9 
1.1 ± 0.3  44.8 ± 
1.7 
0.4 ± 0.2  0.04 
Leg Lean Tissue Mass (kg) 
Baseline 12.9  ± 
0.6 
 12.7  ± 
0.6 
  
Final 13.1  ± 
0.6 
0.2 ± 0.1 12.8  ± 
0.5 
0.1 ± 0.2  0.28 
Muscle Quality 
Baseline  61 ± 5    51 ± 4     
Final  100 ± 6  28 ± 3  48 ± 4  - 4 ± 2 <0.001 
Type I muscle fiber area (µm2) 
Baseline 4068  ± 
256 
 4546  ± 
270 
  
Final 4928  ± 
372 
860 ± 252  4381 ± 
304 
- 164 ± 
290 
0.04 
Type II muscle fiber area (µm2) 
Baseline 3885  ± 
278 
 4330  ± 
346 
  
Final 4605  ± 
283 
720 ± 285  4201 ± 
336 
- 130 ± 
336 
0.04 
Data are the mean ± SE of baseline and final values and of the change on 
each variable in each group.  
Muscle Quality data calculated for all participants. Baseline and 
final muscle biopsies were obtained in a subset of the study 
population (n = 24 ST; n = 18 CON).   
a Time-by-group interactions were assessed by repeated measures 
ANCOVA of baseline and final values for each variable adjusted for 
insulin therapy, change in physical activity and change in diabetes 
medications. 
Secondary analyses  
We further assessed the association of specific 
physiological and biochemical measures and the 
observed changes in type I muscle fiber CSA. Type I 
fibers were chosen for this analysis because they have 
higher insulin sensitivity, greater oxidative capacity, 
more mitochondria, and are more closely associated 
with leanness than type II fibers [32, 33]. In univariate 
analysis, there was a negative correlation between the 
changes observed in type I muscle fiber CSA and those 
seen for HOMA-IR in the ST group (Figure 1A) but not 
in the CON group (Figure 1B). This is in line with the 
strong inverse correlation between glycosylated 
hemoglobin A1C and muscle cross-sectional area 
observed by other investigators [17]. 
There were no associations between the changes 
in CRP, FFA, adiponectin, lower body muscle strength 
or leg lean body mass and the change in type I fiber 
CSA for either group, nor between the changes in 
HOMA-IR with any of the changes observed in CRP, 
FFA, adiponectin levels in either group. Using 
multiple regression models, we found that the change Int. J. Med. Sci. 2007, 4 
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in HOMA-IR was the only independent variable 
negatively associated with the change seen in type I 
muscle fiber CSA after 16 weeks of strength training, 
accounting for 53% of its variability (p=0.03). There 
were no variables significantly associated with the 
change in type I CSA in the CON group.  
Figure 1. Univariate linear association between the absolute change in type I muscle fiber cross-sectional area and the change 
in HOMA-IR for each subject in the ST group (A: r= - 0.50, p=0.01) and the CON group (B: r= - 0.10, p=0.42) are shown. 
 Int. J. Med. Sci. 2007, 4 
 
24
Table 3: Metabolic Parameters 
ST Group    CON Group   
N=31 Change N=31  Change 
P valuea 
Glycosylated Hemoglobin Concentrations (%) 
Baseline 8.7  ± 1.8    7.8 ± 1.6     
Final 7.6  ± 1.5  - 1.0 ± 0.2 8.3  ± 1.3  0.4 ± 0.3 <0.001 
Glucose (mmol/L) 
Baseline  8.8 ± 0.5    9.9 ± 0.7     
Final  7.9 ± 0.4  - 0.9 ± 0.5  9.5 ± 0.6  - 0.3 ± 0.8 0.92 
Insulin (pmol/L) 
Baseline  116 (124)    115 (131)     
Final  105 ( 70)  - 16 (69)  133 (126)  6 (86)  0.27 
HOMA-IR 
Baseline  7.1 (5.7)    6.7 (9.0)     
Final  5.3 (5.5)  - 0.7 (3.6)  6.4 (6.8)  0.8 (3.8)  0.05 
FFA (µmol/L) 
Baseline  656.4 ± 41.9    468.5 ± 38.3     
Final  572.4 ± 45.3  - 83.6 ± 30.3  612.2 ± 53  148.9 ± 47.7  0.02 
CRP (mg/L) 
Baseline  3.5 (9.1)    3.5 (8.4)     
Final 2.8  (2.8)   - 1.3 (2.9)  4.1 (8.1)  0.4 (2.3)  0.05 
Adiponectin (µg/mL) 
Baseline  5.1 (5.3)    8.3 (4.5)     
Final 6.6  (5.4)   1.0 (1.8)  6.7 (4.6)   - 1.2 (2.2)  <0.001 
Data are the mean ± SE or median (interquartile range) for variables not normally distributed (insulin, HOMA-IR, CRP and adiponectin) of baseline 
and final values and of the change on each variable in each group.  
a Time-by-group interactions were assessed by repeated measures ANCOVA of baseline and final values for each variable, adjusted for 
insulin therapy, change in physical activity and change in diabetes medications. 
4.  Discussion  
Sixteen weeks of high intensity strength training 
resulted in increased upper and lower body strength, 
improved muscle quality, and muscle fiber 
hypertrophy. This was paralleled by favorable 
metabolic changes in biochemical parameters known 
to influence insulin sensitivity including increased 
adiponectin levels and decreased FFA and CRP levels. 
The improvements in muscle quality and metabolic 
control were associated with strength training in this 
population of community-dwelling Hispanic older 
adults with diabetes.  
Hypertrophy of type I muscle fibers, such as that 
seen in the present study, is important given that these 
fibers are more insulin sensitive [33]; they contain a 
greater oxidative and mitochondria capacity, and 
higher capillary density [32]. Therefore, it is not 
surprising to find that the muscle hypertrophy 
resulting from strength training was associated with 
the increases in whole-body insulin sensitivity we 
observed, because skeletal muscle constitutes the 
target tissue where most of the insulin-stimulated 
glucose uptake takes place [34].  
There is growing interest in muscle quality which 
has been demonstrated to be a predictor of health 
status and mortality [35, 36] and a better indicator of 
muscle function than strength alone [5]. Elderly 
individuals have reduced muscle quality compared to 
young adults [37], and diabetics have significantly 
lower muscle quality than non-diabetic controls [8]. 
Since in this diabetic group, those undergoing strength 
training significantly increased their muscle quality 
compared to controls, improved muscle quality and 
associated functional capacity derived from exercise 
interventions like this, may ultimately lead to 
increased quality of life and improved disease 
outcomes in people with diabetes.  
We also investigated specific parameters of 
metabolic control known to influence insulin 
sensitivity, including adiponectin, CRP and FFA. 
Plasma adiponectin is positively associated with 
enhanced insulin signal transduction in skeletal 
muscle [38]. In the present study, subjects who 
strength trained showed increased levels of 
adiponectin. Interestingly, other studies investigating 
adiponectin levels have shown varying results. High 
intensity endurance training in nondiabetic 
individuals showed decreased insulin resistance and 
increased adiponectin levels [21]. Four weeks of 
endurance training increased circulating adiponectin 
levels and also mRNA levels of adiponectin receptors 
in muscle [22]. However, another recent study 
demonstrated that higher intensity endurance exercise 
provided greater increases in adiponectin, and 
reductions in insulin resistance in healthy elderly 
subjects than lower intensity exercise [23]. Our study 
further exemplifies this finding with high-intensity 
strength training in elderly diabetic individuals. It has 
recently been reported that insulin resistance causes a 
down-regulation of adiponectin receptors [10], which 
may be mediated by PI3-kinase/FOXO1 dependent 
pathway [10]. Further investigation is needed to 
understand the mechanisms contributing to this 
down-regulation of adiponectin receptors and the 
influence of muscle factors on circulating adiponectin 
levels.  
The inflammatory response is correlated with Int. J. Med. Sci. 2007, 4 
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multiple metabolic markers of insulin resistance. We 
measured CRP, a systemic marker of low-grade 
systemic inflammation [12]. It has recently been shown 
that ten months of aerobic exercise reduced CRP levels 
in elderly subjects [39] and aerobic exercise training 
combined with a dietary intervention in diabetic men 
reduced their CRP levels [40]. The decrease in CRP 
levels we observed in the present study suggests that 
the reduction in the inflammatory state of diabetes 
may be an important factor leading to improved 
insulin sensitivity and better metabolic control. 
Furthermore, since adiponectin has anti-inflammatory 
actions [11] and we showed a significant increase in 
this adipokine, the reduction in inflammation may be 
related to this increase. 
Moreover, the positive impact of strength 
training on whole-body insulin resistance was 
demonstrated by decreased levels of plasma FFA after 
16 weeks of exercise. Plasma FFA negatively influence 
insulin resistance and excess lipid availability leads to 
increased intracellular concentration of FFA and 
triglycerides, particularly in skeletal muscle and liver 
[41]. This phenomenon plays a role in the insulin 
resistance of skeletal muscle and also the increased 
plasma FFA noted in people with diabetes. The 
decrease in circulating FFA may be, in part due to 
increased fatty acid oxidation in skeletal muscle [42] 
and increased adiponectin levels [43]. A reduction in 
FFA leads to the decrease in intramuscular triglyceride 
levels which have found to be associated with 
improved insulin sensitivity [44]. 
This study used a randomized, high-intensity 
strength training program involving a large cohort of 
community-dwelling Hispanic older adults with 
poorly controlled diabetes and provided a practical 
means for improvement in muscle quality and better 
metabolic control. In addition, strength training 
provides a potentially more alluring means of exercise 
for people with type 2 diabetes, the majority of whom 
may be overweight and sedentary for most of their 
lives, and may find endurance exercise unappealing 
and difficult. In this study, the control subjects showed 
an overall worsening of the physiologic, biochemical 
and metabolic variables measured. This may be due to 
poor diabetes self-management often reported among 
people with diabetes or due to the socio-demographic 
characteristics of the study population in terms of 
health care use and access [45].  
It is also noteworthy that at baseline subjects 
randomized to strength training were prescribed more 
insulin therapy than those in the control group. 
However, the beneficial effects of strength training we 
found were seen even in these participants, who by 
virtue of their insulin treatment may have been more 
prone to catabolic effects of diabetes and poorer 
glycemic control, and more resistant to the antidiabetic 
action of strength training. Furthermore, the results 
presented here were all adjusted for insulin use. 
It could be argued that the euglycemic 
hyperinsulinemic clamp technique rather than 
HOMA-IR should have been used as the measure of 
insulin sensitivity [46]. Although the clamp technique 
is considered the gold standard, and a measure of 
choice given its precision, HOMA-IR has been tested 
for its comparability to the gold standard in various 
populations including those with diabetes [47]. 
Moreover, measures of plasma glucose and insulin use 
to derive HOMA-IR are more clinically relevant, and 
their changes can be followed more closely by the 
personal physician of an individual with diabetes. 
The generalizability of these findings is limited 
given the selected population studied. However, 
long-term strength training has been shown to 
improve glycemic control in Caucasians [18] as well as 
in Hispanics [19], suggesting that the beneficial effects 
of this exercise modality are not population specific. 
In order to investigate the mechanisms leading to 
improved insulin sensitivity with exercise training, it is 
necessary to analyze some of the components of the 
insulin signaling pathway in skeletal muscle. Holten et 
al. [48] investigated a number of important 
biochemical muscle adaptations in both diabetic and 
non-diabetic individuals in response to 4 weeks of 
one-legged low-intensity strength training and 
reported possible mechanisms leading to a training 
effect including increased protein content of GLUT4, 
insulin receptor, glycogen synthase and protein-kinase 
B (PKB) without an increase in muscle mass. However, 
they could not draw conclusive functional relevance 
on the changes in components of the insulin signaling 
protein expression. We were unable to investigate such 
mechanisms in the present study given the limited 
tissue obtained and the large variability observed in 
these measures provided by our study sample. 
Interestingly, in the Holten study they used the same 
subject to test one-legged strength training effect as 
compared to the contralateral control leg, to reduce the 
variation seen in these measures [48]. However, given 
the design of this study limited comparisons with our 
study can be made. Thus, further studies are 
warranted to establish the relationship and possible 
mechanisms between strength training and improved 
skeletal muscle insulin sensitivity. In addition, the age 
of participants, type of exercise training, and study 
design need further investigation in relation to 
changes in the insulin cascade, to provide more 
conclusive and comparable evidence. 
In conclusion, the findings of the present study 
suggest that 16 weeks of strength training results in 
improved muscle quality, skeletal muscle fiber 
hypertrophy, accompanied by concomitant changes in 
biochemical markers known that contribute to 
whole-body insulin sensitivity; namely, reduced 
HOMA-IR, increased adiponectin levels and decreased 
FFA and CRP levels. Further studies are needed to 
establish the mechanisms associated with these 
relationships. However, these data show that strength 
training is an exercise modality worth considering as 
an adjunct of standard of care for high risk populations 
with diabetes. Int. J. Med. Sci. 2007, 4 
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